Tumor enucleation for small renal masses

Nicholas A Laryngakis1, Thomas J Guzzo

  • 1Division of Urology, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Abstract

Insights

Tumor enucleation offers oncologic outcomes equivalent to partial nephrectomy for select renal masses. This nephron-sparing technique is increasingly accepted for localized renal cell carcinoma, preserving kidney function.

Area of Science:

  • Urology
  • Oncology
  • Nephrology

Background:

  • Rising incidence of renal cell carcinoma and incidental small renal masses presents management challenges.
  • Radical nephrectomy was traditional, but nephron-sparing surgery is preferred due to risks of renal insufficiency.
  • Partial nephrectomy is the established standard for localized renal masses.

Purpose of the Study:

  • To review the oncologic outcomes of tumor enucleation compared to partial nephrectomy for small renal masses.
  • To assess the safety and efficacy of enucleation in anatomically challenging scenarios.
  • To evaluate the growing acceptance of enucleation as a nephron-sparing surgical option.

Main Methods:

  • Review of existing data comparing partial nephrectomy and tumor enucleation.
  • Analysis of oncologic outcomes, including recurrence and metastasis rates.
  • Evaluation of surgical technique focusing on the plane between pseudocapsule and parenchyma.

Main Results:

  • Partial nephrectomy demonstrates equivalent oncologic outcomes to radical nephrectomy.
  • Tumor enucleation shows equivalent oncologic outcomes to partial nephrectomy.
  • Enucleation is performed by dissecting along the natural plane, sparing renal parenchyma.

Conclusions:

  • Tumor enucleation is a safe and effective alternative for localized renal masses.
  • Acceptance of enucleation is increasing for masses confined by preoperative imaging and intraoperative delineation.
  • Enucleation preserves renal parenchyma and function, offering a valuable nephron-sparing option.